• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Virginia Commonwealth University - Developmental Therapeutics Review - Q4 2010 Product Image

Virginia Commonwealth University - Developmental Therapeutics Review - Q4 2010

  • Published: December 2010
  • Region: Global, Virginia
  • 75 pages
  • Global Markets Direct

Virginia Commonwealth University – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Virginia Commonwealth University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Virginia Commonwealth University.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Virginia READ MORE >



List of Tables
List of Figures
Virginia Commonwealth University Snapshot
Virginia Commonwealth University Overview
Key Information
Key Facts
Virginia Commonwealth University – Research and Development Overview
Key Therapeutic Areas
Virginia Commonwealth University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Virginia Commonwealth University – Pipeline Products Glance
Virginia Commonwealth University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Virginia Commonwealth University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Virginia Commonwealth University–Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Virginia Commonwealth University – Drug Profiles
Anakinra
Product Description
Mechanism of Action
R&D Progress
Botox
Product Description
Mechanism of Action
R&D Progress
D-chiro-inositol
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Cyclophosphamide + Cyclosporine + Cytarabine + Methotrexate + Methylprednisolone
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Cyclophosphamide + Cyclosporine + Cytarabine + Methotrexate + Methylprednisolone
Product Description
Mechanism of Action
R&D Progress
3'-Deoxy-3'-18F Fluorothymidine
Product Description
Mechanism of Action
R&D Progress
5-azacytidine
Product Description
Mechanism of Action
R&D Progress
Bryostatin 1 + Cytarabine
Product Description
Mechanism of Action
R&D Progress
Carvedilol
Product Description
Mechanism of Action
R&D Progress
Etanercept
Product Description
Mechanism of Action
R&D Progress
Lovastatin
Product Description
Mechanism of Action
R&D Progress
Revlimid + Azacitidine + Autologous Stem Cell Transplantation + Therapeutic Autologous Lymphocytes
Product Description
Mechanism of Action
R&D Progress
Thymoglobulin
Product Description
Mechanism of Action
R&D Progress
Zoledronic Acid
Product Description
Mechanism of Action
R&D Progress
aldesleukin + bryostatin 1
Product Description
Mechanism of Action
R&D Progress
alvocidib + bortezomib
Product Description
Mechanism of Action
R&D Progress
Alvocidib + Gleevec
Product Description
Mechanism of Action
R&D Progress
Alvocidib + Vorinostat
Product Description
Mechanism of Action
R&D Progress
Bortezomib + Flavopiridol
Product Description
Mechanism of Action
R&D Progress
Bortezomib + Romidepsin
Product Description
Mechanism of Action
R&D Progress
Bryostatin 1 + Cytarabine
Product Description
Mechanism of Action
R&D Progress
Bryostatin 1 + High Dose Cytarabine
Product Description
Mechanism of Action
R&D Progress
Cytarabine + Deoxycytidine
Product Description
Mechanism of Action
R&D Progress
Dacarbazine + bortezomib
Product Description
Mechanism of Action
R&D Progress
Dacarbazine+bortezomib
Product Description
Mechanism of Action
R&D Progress
Flavopiridol + Imatinib Mesylate
Product Description
Mechanism of Action
R&D Progress
Interleukin-2 + Bryostatin-1
Product Description
Mechanism of Action
R&D Progress
PXD-101 + Velcade
Product Description
Mechanism of Action
R&D Progress
Sorafenib + Vorinostat
Product Description
Mechanism of Action
R&D Progress
Sorafenib tosylate + Vorinostat
Product Description
Mechanism of Action
R&D Progress
Voriconazole
Product Description
Mechanism of Action
R&D Progress
AEG-1 inhibitors
Product Description
Mechanism of Action
R&D Progress
Virginia Commonwealth University – Pipeline Analysis
Virginia Commonwealth University – Pipeline Products by Therapeutic Class
Virginia Commonwealth University Pipeline Products By Target
Virginia Commonwealth University – Pipeline Products by Route of Administration
Virginia Commonwealth University – Pipeline Products by Molecule Type
Virginia Commonwealth University - Dormant Projects
Virginia Commonwealth University - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Celecoxib
Virginia Commonwealth University – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Dec 16, 2008: Researchers Identify New Anti-Tumor Gene
Financial Deals Landscape
Virginia Commonwealth University, Deals Summary, 2004 to 2010
Virginia Commonwealth University Detailed Deal Summary
Oxygen Biotherapeutics Enters Into Joint Venture Agreement With Virginia Commonwealth University
Licensing Agreements
Synthetic Blood International Enters Into Licensing Agreement With Virginia Commonwealth University
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS